Use of Two Enzyme Inhibitors in Hypertension Therapy

Abstract

Greater individualization of treatment in severe hypertension may be possible as the number of available antihypertensive drugs increases.

Two enzyme inhibitors, pargyline and methyldopa, appear in preliminary observations to be useful in treating severe hypertension. Situations in which either compound could be substituted for guanethidine are described.